(Circulation. 2000;102:1212.)
© 2000 American Heart Association, Inc.
Cardiovascular News |
I am pleased to announce that the National Heart, Lung, and Blood Institute (NHLBI) will reestablish its intramural cardiac surgery program this year.
Before I explain our rationale for reinstituting the program, let me briefly review the history of the previous cardiac surgery program at the NHLBI and that programs termination. As some of the readership may recall, in 1990, the NHLBI found itself in the regrettable position of having to dismantle its highly regarded intramural cardiac surgery program. At that time, however, we had little choice. Our decision was thoroughly considered and carefully based on several key factors.
The first of these factors was the changing nature of the cardiology research program. The NHLBIs Cardiac Surgery Branch had made outstanding contributions to the fields of clinical surgery and surgery research, especially in the areas of valve replacement procedures and treatment of hypertrophic cardiomyopathy. However, the field of cardiology and cardiac surgery soon progressed to the point that many of these once-innovative techniques had become accepted as standard clinical practice. At that point, the NHLBI was no longer driving cutting-edge research in cardiac surgery. In fact, we had made the decision to emphasize and pursue newer, molecular biology approaches for the treatment of cardiac disease.
The second factor influencing our decision to discontinue the program
was an inability to recruit and maintain a permanent cadre of surgeons.
One reason for this was the perception that the program was not a
professional challenge because of the limited volume and nature of
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |